LOGC

LogicBio Therapeutics Inc.

Price

$14.77

return (12m)

84.86%

p/e

-30.53

p/bv

0.93

DIVIDEND YIELD

0.00%

LOGC price

LogicBio Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LOGC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

24.12%

3 months

69.77%

1 year

84.86%

2 years

183.49%

5 years

-90.33%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals LOGC

Valuation

P/E

-30.53

Sector -3.50

Industry -3.50

P/BV

0.93

Sector 2.01

Industry 2.01

P/Revenue (PSR)

20.26

Sector 2.01

Industry 2.01

EV/EBITDA

-462.74

Sector -223.67

Industry -223.67

EV/EBIT

-462.74

Sector -47.92

Industry -47.92

P/EBITDA

-34.21

Sector -21.50

Industry -21.50

P/EBIT

-34.21

Sector -28.21

Industry -28.21

P/Total Assets

0.70

Sector 1.19

Industry 1.19

P/Net Current Assets

-3.53

Sector -10.26

Industry -10.26

P/Working Capital

36.80

Sector -167.98

Industry -167.98

EPS

-0.48

Sector -1.79

Industry -1.79

BVPS

15.99

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

37.20%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-5.65%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-5.65%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-54.17%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-66.37%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.03

Sector 0.02

Industry 0.02

Profitability

ROE

-3.03%

Sector -56.67%

Industry -56.67%

ROA

-2.30%

Sector -59.91%

Industry -59.91%

ROIC

-0.09%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.87

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-104.42

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

-104.42

Sector -8.06

Industry -8.06

Net Debt / Equity

0.27

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.28

Sector -0.85

Industry -0.85

Equity/Assets

0.76

Sector 0.46

Industry 0.46

Liabilities/Assets

0.24

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-56.20%

Sector -

Industry -

5Y Earnings CAGR

-42.70%

Sector -

Industry -

Fundamentals LOGC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LOGC LogicBio Therapeutics Inc.	$14.77	84.86%	0.00%	-30.53	0.93	-3.03%	-66.37%
JNJ Johnson & Johnson	$270.61	56.72%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$28.50	26.43%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.75	22.26%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.47	-31.25%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$149.22	93.94%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$164.92	11.31%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$60.81	43.25%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$70.80	-49.40%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$405.08	45.13%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$798.06	38.86%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$114.66	47.81%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$881.77	19.56%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$523.68	37.91%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.25	46.88%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$952.35	29.68%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$41.31	28.80%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LOGC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT LogicBio Therapeutics

LogicBio Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

12 years

Founded: 2014

2018

Time since IPO - 8 years

39

Employees

LogicBio Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $680.80 million, with shareholders equity totaling $735.50 million.

The company employs approximately 39 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, LogicBio Therapeutics Inc. reported $33.60 million in revenue, generating net income of $-22.30 million.

Key financial metrics include a P/E ratio of -30.53, a price-to-book (P/B) ratio of 0.93, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LOGC.

Market cap

$680.80 million

Net worth

$735.50 million

$735,500,000.00

Assets

$967.80 million

$967,800,000.00

Total Shares Outstanding

46.00 million

46,000,000

Average Daily Trading Volume

$135.25 Thousand

$135,249.20

Sector

Health Care

Industry

Biotechnology

LOGC

LOGC revenue and profits

Financial Results LOGC

DRAG THE FRAME TO SEE MORE DATA

LOGC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$881.77 16,53% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.25 46,92% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$270.61 56,62% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.75 23,72% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$149.22 94,65% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$164.92 14,08% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$28.50 26,64% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$881.77 16,53% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.25 46,92% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$270.61 56,62% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.75 23,72% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$149.22 94,65% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$164.92 14,08% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$28.50 26,64% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of LogicBio Therapeutics (LOGC) today?

The current price of LogicBio Therapeutics (LOGC) is $14.77. The stock began the year trading around $7.58 and is currently priced at $14.77. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does LogicBio Therapeutics (LOGC) pay dividends?

LogicBio Therapeutics (LOGC) did not pay dividends over the past year.

Is LogicBio Therapeutics (LOGC) a good investment?

LogicBio Therapeutics (LOGC) is currently trading at $14.77 with a P/E ratio of -30.53. This represents a -1,314% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 84.86%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy LogicBio Therapeutics (LOGC) stock?

You can buy LogicBio Therapeutics (LOGC) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol LOGC and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of LogicBio Therapeutics (LOGC) yield today?

Over the past month, LogicBio Therapeutics (LOGC) has returned 24.12% — 84.86% over the past year, and -90.33% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of LogicBio Therapeutics (LOGC) today at the current price of $14.77 your total investment would be $1,477.00.

Based on historical performance, the investment would have grown to approximately:

$2,730.38 after 1 year
$142.83 after 5 years
$1,477.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LOGC

LogicBio Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LOGC

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING LOGC WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT LogicBio Therapeutics

LogicBio Therapeutics Inc.

United States

12 years

2018

39

PROFIT X PRICE LOGC

Financial Results LOGC

LOGC cash flow

Asset, Revenue and Profit Growth - LOGC

LOGC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions